PIAS
GILD icon

PCA Investment Advisory Services’s Gilead Sciences GILD Stock Holding History

PCA Investment Advisory Services’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-322
Closed -$24.8K – 230
2023
Q2 		$24.8K Buy
+322
New +$25.7K 0.01% 331

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

PCA Investment Advisory Services's GILD Position: Q3 2023 in Review

PCA Investment Advisory Services sold out of Gilead Sciences (GILD) in Q3 2023, closing a stake of 322 shares — an estimated $24.8K sold.

PCA Investment Advisory Services first reported a position in GILD in Q2 2023 and held it in 1 quarter. The position peaked at $24.8K in Q2 2023. 1,681 funds tracked by Wall St. Rank hold GILD as of Q3 2023.

  • PCA Investment Advisory Services reported no remaining Gilead Sciences position as of Q3 2023 after selling out during the quarter.
  • PCA Investment Advisory Services sold 322 Gilead Sciences shares in Q3 2023, an estimated $24.8K.
  • PCA Investment Advisory Services first reported a position in Gilead Sciences in Q2 2023 and held it in 1 quarter.
  • PCA Investment Advisory Services's Gilead Sciences position peaked at $24.8K in Q2 2023.
  • 1,681 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2023.

Based on PCA Investment Advisory Services's 13F filing for Q3 2023, filed 13 Nov 2023.